Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.
Tasca has raised $52.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
Tasca's investors include Invus, Cure Ventures, Regeneron Ventures.
Tasca is headquartered in Boston, United States.
Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.
Tasca is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tasca — Funding & Investors." VCBacked, December 10, 2024, https://www.vcbacked.co/company/tasca. Accessed September 3, 2026.
VCBacked. (2024). Tasca — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/tasca
{{cite web |title=Tasca — Funding & Investors |url=https://www.vcbacked.co/company/tasca |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated